เดือน: กุมภาพันธ์ 2026

HONG KONG, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) – As the joint sponsor, overall coordinator, joint global coordinator, joint bookrunner and joint lead manager, Guotai Junan International Holdings Limited (“GTJAI”, stock code: 1788.HK), a company of Guotai Haitong Group, successfully assisted Axera Semiconductor Co., Ltd. (“Axera”, stock code: 600.HK) in its official listing on the Main Board of the Hong Kong Stock Exchange on February 10. This listing enriches the investment options in the Hong Kong stock market for edge AI inference system chips and demonstrates Guotai Haitong Group’s comprehensive strength in serving semiconductor technology companies.Axera is a provider of artificial intelligence (“AI”) inference systems-on-a-chip (“SoC”), delivering high-performance perception and computing platforms for edge and endpoint AI applications. It is building an advanced AI computing infrastructure to make artificial intelligence accessible to everyone. According to its prospectus, Axera is the largest provider of mid-to-high-end visual on-device AI inference chips in the world and ranks among the top five players in the global visual on-device AI Inference chip market, in terms of the shipments in 2024. Its Axera Proton AI-ISP is the world’s first AI-ISP technology commercialized at scale, marking a significant milestone in the computer vision industry. As of September 30, 2025, Axera had cumulatively delivered over 165 million SoC units since its inception. AXERA had independently developed and commercialized five generations of SoCs, spanning dozens of types, that have achieved large-scale production in visual on-device computing, smart vehicle and edge AI inference applications.The offer price is HK$28.20 per share, with a total of 104,915,200 H shares in the Global Offering and base proceeds from the offering of approximately HK$2,959 million. If the over-allotment option is fully exercised, the total proceeds are expected to reach approximately HK$3,402 million. Both the International Offering and the Hong Kong Offering were met with enthusiastic subscription, with the International Offering oversubscribed by approximately 6.8 times and the Hong Kong Offer oversubscribed by approximately 104.82 times. The offering successfully attracted cornerstone investors including WILL Semiconductor, Xin Ma Apparel, JSC Fund, NGS Super, Desay SV, Factorial Fund, Hel Ved Fund, Valliance, and Alphahill Capital. These cornerstone investors collectively subscribed to approximately HK$1,443 million worth of shares, accounting for about 48.76% of the total shares. This not only fully demonstrates the market’s recognition of AXERA’s business model and long-term development prospects, but also provides support for the stability of the post-listing stock price.The success of this project highlights GTJAI’s deep understanding of the artificial intelligence chip industry and its professional ability to serve high-tech industries. Moving forward, Guotai Haitong Group will continue to focus on the field of technological innovation, fully leverage its integrated domestic and international collaborative advantages, and rely on its full-chain financial services system to provide comprehensive empowerment—from capital operations to strategic resource integration—for more hard-tech enterprises. This will assist them in efficiently connecting with global capital markets and jointly exploring the new era of intelligence.About GTJAIGuotai Junan International (Stock Code: 1788.HK), a subsidiary of Guotai Haitong Group, is the market leader and first mover for internationalization of Chinese Securities Company as well as the first Chinese securities broker listed on the Main Board of The Hong Kong Stock Exchange through initial public offering. Based in Hong Kong with subsidiaries in Singapore, Vietnam and Macau, GTJAI’s business covers major markets around the world, offering high-quality and diversified comprehensive financial services for clients' overseas asset allocation. Core business includes wealth management, institutional investor services, corporate finance services, investment management and other business. GTJAI has been assigned “Baa2” and “BBB+” long term issuer rating from Moody and Standard & Poor respectively, as well as an MSCI ESG “A” rating, Wind ESG “A” rating and SynTao Green Finance “A” rating in ESG. Additionally, its S&P Global ESG score leads 81% of its global peers. The controlling shareholder, Guotai Haitong Securities (Stock Code: 601211.SH/ 2611.HK), is the comprehensive financial provider with a long-term, sustainable and overall leading position in the China’s capital markets. For more information about GTJAI, please visit https://www.gtjai.com. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BOSTON, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects with laboratory-confirmed acute viral infection. The Bioxyytran Trial reports complete elimination of viral load  in 100% of patients at day 7 versus placebo (p=.001).The completed Phase 2 clinical study was a randomized, double-blind, placebo-controlled, dose-optimization trial evaluating orally administered ProLectin-M in subjects with acute viral infection. The study enrolled 38 subjects, all of whom completed the study. Subjects were randomized to receive one of three ProLectin-M dose levels or a matching placebo, administered over a seven-day treatment period.Viral shedding was assessed using RT-PCR analysis of nasopharyngeal swabs collected at predefined timepoints, with viral clearance defined as non-detection of viral RNA below established PCR thresholds.The study design, endpoints, and duration confirmed Bioxytran’s earlier randomized, placebo-controlled Phase 2 trial, which demonstrated statistically significant reductions in viral load by Day 7, early clearance as soon as Day 3, and no observed viral rebounds during a 14-day post-treatment observation period. The current trial further refined dose selection of four tablets per day and evaluated the reproducibility of rapid viral clearance using the same core virologic assessment methodology.Topline Viral Clearance ResultsFollowing database lock and unblinding, treatment-wise analyses demonstrated the following outcomes:Complete elimination of viral load in 100% of treated subjects by Day 7, compared to the placebo group (p = .001)No viral rebounds observed in the treated population during the 14-day post-treatment observation periodThese results indicate rapid and sustained viral clearance in subjects treated with ProLectin-M.Viral Clearance Timing (All Subjects)Across the full study population:Day 3: 1 of 38 subjects demonstrated non-detection of viral sheddingDay 5: 16 of 38 subjects demonstrated non-detection of viral sheddingDay 7: 38 of 38 subjects demonstrated non-detection of viral sheddingThe study was designed to evaluate viral clearance kinetics and inform dose selection for future late-stage clinical development.“The study design of seven days reflects real-world applications for treating acute viral diseases, with the objective of demonstrating a statistically meaningful reduction in viral load by Day 7,” said Dr. Leslie Ajayi, Chief Medical Officer of Bioxytran. “The results demonstrate that viral clearance occurred more rapidly than anticipated, with a significant proportion of treated subjects achieving viral non-detection by Day 3 and complete clearance by Day 7.”“What continues to distinguish ProLectin-M as a broad-range antiviral drug is its novel mechanism of action,” Dr. Platt continued. “Rather than targeting viral replication inside the cell, our galectin antagonist is designed to interfere with viral entry at the cell surface. This extracellular approach may reduce reliance on immune activation and represents a fundamentally different strategy in antiviral therapy. We believe these results further support the potential of carbohydrate-based therapeutics and the emerging field of Glycovirology.”Next StepsBased on these results, Bioxytran plans to advance regulatory discussions to support late-stage clinical development and evaluate ProLectin-M across additional viral indications consistent with its broad-spectrum antiviral profile.About Bioxytran, Inc.Bioxytran, Inc. is a clinical-stage biotechnology company developing novel carbohydrate-based therapeutics targeting significant unmet medical needs in virology and other disease areas. The Company’s lead program, ProLectin-M, is being developed as a potential broad-spectrum antiviral therapeutic.For more information, please visit www.bioxytraninc.com.Investor & Media Contact:Bryan Feinberg / AmplifiXZephyr@amplifiX.net Company Contact:david.platt@bioxytraninc.com(617) 510-2539Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of applicable federal securities laws, including statements regarding the performance of the technology described herein, the interpretation of clinical trial results, regulatory plans, and future development activities. Forward-looking statements are generally identified by words such as “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” and similar expressions, although not all forward-looking statements include these terms. Such statements are subject to significant risks, uncertainties, and assumptions that could cause actual results to differ materially from those expressed or implied. These risks are described in Bioxytran’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and other filings made from time to time. Bioxytran undertakes no obligation to update or revise any forward-looking statements, except as required under applicable securities laws. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Engagement Strengthens European Investor Outreach as Critical Minerals and Defence Partnerships AccelerateOttawa, Ontario--(ACN Newswire via SeaPRwire.com - February 11, 2026) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a leading developer of high-grade flake graphite deposits and advanced graphite materials for battery, defence, and industrial applications, is pleased to announce that it has engaged Dr. Reuter Investor Relations ("Dr. Reuter") to provide investor awareness and communications services across Germany and the broader European capital markets, effective February 16, 2026.Dr. Reuter is a recognized European investor relations and financial communications firm with an established network of institutional investors, retail shareholders, and financial media throughout the DACH region and the European Union. The engagement is intended to enhance Focus Graphite's visibility among European investors, support market education regarding its vertically integrated graphite strategy, and strengthen shareholder communications as development advances across the Company's flagship projects and downstream processing initiatives. Dr. Reuter's business address is Tower 185, Friedrich-Ebert-Anlage 35-37, 60327 Frankfurt, Germany, and the firm may be contacted at e.reuter@dr-reuter.eu."We are seeing growing strategic and institutional interest from European markets in secure critical minerals supply chains, particularly for battery materials, defence, and advanced industrial applications," said Dean Hanisch, CEO of Focus Graphite. "European stakeholders are increasingly focused on diversifying supply away from highly concentrated sources of graphite. Engaging Dr. Reuter strengthens our ability to communicate directly with German and broader European capital markets, expand institutional awareness, and improve investor access as we advance our resource development and technology initiatives."The engagement comes at a time of accelerating European policy and industrial focus on securing domestic and allied sources of critical raw materials. European governments and industrial stakeholders are increasingly prioritizing supply chain resilience, diversification away from highly concentrated foreign sources, and long-term access to graphite and other materials supporting battery, energy storage, defence, and broader dual-use industrial applications. Initiatives tied to defence readiness and industrial capacity, including frameworks such as the European Union's "ReArm Europe" strategy, are reinforcing demand for secure, traceable, and jurisdictionally aligned graphite supply. The Company believes its high-grade natural graphite resources and downstream processing strategy are well aligned with these evolving European defence and dual-use supply chain priorities.Complementing this engagement, the Company will be participating in the Canadian Critical Minerals Mission to Europe taking place February 16-20, 2026, with scheduled engagements in Rome, Munich, and Paris alongside representatives from Natural Resources Canada and Invest in Canada. The mission is expected to facilitate direct dialogue with government stakeholders, industrial partners, and institutional investors, supporting the advancement of secure transatlantic critical minerals supply chains and expanding strategic relationships across European capital markets and downstream industrial sectors.Under the terms of the agreement, Dr. Reuter will provide investor relations and financial public relations services across European capital markets, including campaign and editorial articles, translation and distribution of press releases, journalist targeting, social media outreach, and ongoing performance reporting. The agreement commences February 16, 2026 and runs for an initial six-month term ending August 16, 2026, at a monthly fee of €4,000. The agreement includes a performance review after three months, at which time the Company may terminate the engagement within seven days without penalty if services are not meeting expectations. Following the initial term, the agreement may be renewed upon mutual consent of both parties. Dr. Reuter is arm's length to the Company and, to the knowledge of the Company, holds no securities of Focus Graphite.About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defence, and advanced materials industries.Our Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining — we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals — reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc., please visit http://www.focusgraphite.com.LinkedIn: https://www.linkedin.com/company/focus-graphite/ X: https://x.com/focusgraphiteInvestors Contact: Dean Hanisch CEO, Focus Graphite Inc. dhanisch@focusgraphite.com +1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, without limitation: (i) the expected services to be provided by Dr. Reuter Investor Relations pursuant to the investor relations and communications agreement; (ii) the anticipated benefits of the engagement, including increased visibility, investor awareness, and shareholder communications across German and broader European capital markets; (iii) the Company's participation in the Canadian Critical Minerals Mission to Europe, including scheduled engagements in Rome, Munich, and Paris; (iv) the potential outcomes of such engagements, including the development of relationships with government stakeholders, industrial partners, and institutional investors; and (v) the Company's broader strategy to expand its presence and positioning within European critical minerals and advanced materials markets.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283521 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SAN DIEGO, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA-ASI) was competitively selected by the U.S. Marine Corps (USMC) for evaluation in the Marine Air-Ground Task Force Uncrewed Expeditionary Tactical Aircraft (MUX TACAIR) Collaborative Combat Aircraft (CCA) program. The agreement integrates GA-ASI's expertise in autonomy and uncrewed aircraft systems with a government-provided mission package, usingthe YFQ-42A platform as a surrogate to evaluate integration with crewed fighters.The contract initiates integration of a Marine Corps mission kit into the YFQ-42A surrogate platform for assessment within the Marine Air Ground Task Force (MAGTF).The USMC contract includes the rapid development of autonomy for the government-supplied mission kit - a cost-effective, sensor-rich, software-defined suite capable of delivering kinetic and non-kinetic effects - positioning the solution for use in expeditionary operations. This work will support evaluations of future MUX TACAIR capabilities."This selection builds upon the GA-ASI autonomous systems in use today and demonstrates our commitment to delivering next generation capabilities for critical USMC missions," said Mike Atwood, Vice President of Advanced Programs for GA-ASI. "Our FQ-42, combined with our proven autonomy architecture and integration expertise, positions us to rapidly deliver an affordable CCA solution that enhances the Marine Air-Ground Task Force's operational effectiveness in contested environments."GA-ASI was selected by the U.S. Air Force in April 2024 to build production-representative flight test articles for the CCA program. The YFQ-42A successfully conducted its maiden flight in August 2025, validating a "genus/species" concept for rapid, modular, and low-cost uncrewed fighter aircraft development. This approach enables a common core aircraft design that can be rapidly adapted for different mission sets and service requirements.The YFQ-42A is a purpose-built CCA platform developed as part of GA-ASI's ongoing investment in next-generation autonomous combat aircraft. The aircraft's modular design enables rapid integration of mission systems. GA-ASI's autonomy architecture, demonstrated through multiple live flight tests, provides the foundation for human-machine teaming in complex combat scenarios.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.GA-ASI Media RelationsGeneral Atomics Aeronautical Systems, Inc.ASI-MediaRelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

LONDON, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - Diets high in meat, eggs, and dairy products incur significant environmental costs. But a new study has revealed that, in many cases, switching your dog to a more sustainable diet may have a bigger impact on the planet and farmed animals than changing your own diet.The research, published in the journal Animals by veterinary Professor Andrew Knight, found that the average dog consumes around 13 farmed land animals annually within its diet, compared with nine for the average person--a difference of roughly 40%. This gap exists largely because a greater proportion of a typical dog's dietary energy comes from animal-based ingredients--about 34%--compared to around 19% for people.These figures represent global averages and vary by country. In high-income nations such as the United States, consumption is higher across the board. There, an average person consumes 24 farmed land animals annually, compared with 20 for a dog--a smaller difference of about 20%.Traditional meat-based pet foods therefore have substantial environmental and animal welfare impacts. However, alternatives based on plants, microbial protein, and cultivated meat are becoming more widely available. Fully plant-based, or vegan, pet foods can now be easily purchased from online retailers in many countries. By early 2026, 14 studies and one systematic review had reported good health outcomes for dogs or cats fed such diets. However, pet diets should be produced by responsible manufacturers and fully supplemented to ensure all necessary nutrients are included.The potential benefits are substantial. If all pet dogs switched to nutritionally sound vegan diets, six billion land animals could be spared from slaughter each year. Greenhouse gas savings would be 1.5 times the UK's annual emissions, and the food energy conserved could feed 450 million people--the population of the European Union. These calculations are based on 2018 data, and with dog populations growing faster than human populations, the potential benefits are even greater today.After analysing survey responses from thousands of pet carers, Knight also estimated that at least 150 million dogs and cats could realistically be transitioned to nutritionally sound vegan diets. However, because the analysis assumed only one dog or cat per household, he noted that the true numbers are probably several times higher.The study evaluated sustainable pet diets using the principles of effective altruism, a philosophy that prioritises issues based on scale, neglect, and solvability, in order to maximise benefits. It found sustainable pet diets to be highly neglected, with only about two full-time researchers worldwide outside pet food companies, and less than one percent of the farmed animal advocacy movement's annual budget devoted to it.Knight concluded that plant-based pet diets represent a powerful but overlooked way to reduce farmed animal use, improve food security, and address climate and biodiversity challenges. He urged animal and environmental advocates to look beyond a solely human-focused approach to more sustainable diets. "It's ironic", he said, "that the animal advocacy movement has largely overlooked the diets of its own companion animals."Prof. Andrew Knighta.knight@griffith.edu.auSOURCE: Sustainable Pet Food Foundation Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute.SAN FRANCISCO / MUMBAI, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - CleverTap, the all-in-one customer engagement platform, today announced that they have been positioned by Gartner® as a Leader in their 2026 Magic Quadrant™ for Personalization Engines.We believe this recognition underscores the progress we are making alongside our customers, a growing ecosystem of forward-looking brands and partners dedicated to delivering relevant, responsible, and effective personalization.Our approach to hyper-personalization, individualized to each customer,  is built around agentic AI capabilities from CleverAI™ designed to deliver "Experience of One” through 1:1 engagement at scale. We believe the CleverAI™ Decisioning Engine plays a central role in interpreting customer intent, enabling brands to connect customers with the right message, on the right channel, at the right moment. Combined with a comprehensive suite of personalization capabilities, we believe these capabilities are helping brands drive measurable outcomes, including up to 35% higher conversion rates across key use cases in industries like financial services, retail, ecommerce, media, telecom, and many others.At the core of this approach is CleverAI™, our enterprise-grade agentic intelligence and decisioning engine. Designed for autonomous real-time orchestration, it enables continuous experience optimization across the customer lifecycle. We believe this focus on unified intelligence, real-time decisioning, and scalable hyper-personalization has contributed to our broader market momentum.“We consider our positioning in the Leaders Quadrant by Gartner as confirmation of our capability that enables customers to improve business outcomes with the power of CleverAI™,” said Anand Jain, Co-founder and Chief Marketing Officer, CleverTap.“We continue to innovate while we execute on our product roadmap. With CleverAI™, we are delivering a truly revolutionary AI-First Customer Engagement Platform that will change the face of the martech and customer engagement industry, further enhancing our market position”.View a complimentary copy of the Magic Quadrant report to learn more about CleverTap’s strengths and cautions, among other provider offerings, here.(Gartner, “Magic Quadrant for Personalization Engines,” by Penny Gillespie, Jason Daigler, Michael Ro, Ross Cosner, 3 February 2026.)Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates.Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.About CleverTapCleverTap is the world’s leading AI-first, all-in-one customer engagement and retention platform, helping brands turn data into lasting customer relationships. Powered by its proprietary CleverAI™: Decisioning Engine and Agentic AI-verse, CleverTap enables organizations to maximize customer lifetime value at scale. Its unified platform brings together AI-powered segmentation, personalization, experimentation, journey orchestration, and deep analytics—seamlessly integrated with 100+ leading martech solutions.With backing from global investors including Accel, Peak XV Partners, Tiger Global, CDPQ, and 360 One, CleverTap has presence across  US, Europe, the Middle East, Latin America, and Asia. Leading brands such as TD Bank, Burger King, Paytm, Levi’s, IKEA, Decathlon, Vodafone, Domino’s, Jio, Carousell, Banco Azteca, Zomato, StockX, and Emirates NBD,  rely on CleverTap to drive measurable growth through meaningful customer engagement.For more information, visit clevertap.com or follow us on:LinkedIn: https://www.linkedin.com/company/clevertap/X: https://twitter.com/CleverTapForward-Looking StatementsSome of the statements in this press release may represent CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. CleverTap cautions that such statements are naturally subject to risks and uncertainties that could result in the actual outcome being absolutely different from the results anticipated by the statements mentioned in the press release.Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated or revised status of such statements. Therefore, in no case whatsoever will CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction.For more information:ADITYA SANYALDirector, Digital Marketing, CleverTap+91 9177110080aditya.sanyal@clevertap.comASHMIT CHAUDHARYAssociate Consultant, Archetype+91 8850752121ashmit.chaudhary@archetype.co Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - Asia’s longest-running sustainability event is coming to Bangkok. On 23 April 2026, the 18th Annual Global CSR & ESG Summit & Awards 2026 lands in Thailand’s vibrant capital, bringing together global leaders, innovators, and changemakers for a high-energy, future-focused gathering that redefines what a sustainability summit can be.Guided by the theme “AI, Energy & Transition: Resetting ESG in a New Economy,” this flagship Summit reimagines the traditional conference into an immersive, high-impact experience—bringing together innovation, leadership, and purpose on one dynamic stage.More than a conference, the Summit combines visionary discussions with inspiring award moments, exploring sustainability in an era shaped by AI, energy transition, and geopolitical change. Through immersive presentations, thought-provoking panels, and four integrated award segments, participants will examine how these forces are reshaping corporate responsibility—and whether ESG is evolving fast enough for a digitised, energy-hungry world.The refreshed format blends insight with inspiration, featuring cinematic storytelling, live performances, and real-world case studies that spotlight purpose-driven leadership and transformational impact.With over 60 companies already confirmed from across Asia and beyond, momentum is strong.Organisations are also invited to participate in the 18th Annual Global CSR & ESG Awards™️ 2026, recognising initiatives that demonstrate measurable impact, strong governance, and strategic foresight.Award Categories Include:- Best Environmental Excellence Award- Best Community Programme Award- Excellence in Provision of Literacy & Education Award- Empowerment of Women Award- Best Workplace Practices- Product Excellence Award- CSR & ESG Leadership Award- Best CEO | Best CFO- Best Corporate Communications & Investor Relations TeamBest Country Awards: Singapore | Malaysia | Thailand | Philippines | India | Indonesia | Cambodia | Vietnam | Middle EastAs ESG expectations rise, the Summit offers a timely platform for meaningful dialogue, practical insights, and recognition of credible initiatives—set against the vibrant backdrop of Bangkok.Join us to ignite action, celebrate excellence, and help redefine ESG for a rapidly changing global economy.For more information visit the official Website: https://globalcsr.pinnaclegroup.global/For Media Inquiries:Eric KhooConference Director18th Annual Global CSR & ESG Summit & Awards™️eric.khoo@pinnaclegroup.globalHDP / WhatsApp: +65 8383 2480 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com